Santen launches Ducressa for post-cataract surgery

August 16, 2022
Manufacturing and Production

Treatment involves a combination of levofloxacin and dexamethasone for use after cataract surgery Santen has announced the launch of Ducressa …

The impact of COVID-19 on the fight against AMR

August 16, 2022
Manufacturing and Production

How the responses to the COVID-19 pandemic have affected antibiotic-resistant bacteria   Responses to the COVID-19 pandemic may have impacted …

BrainStorm’s ALS-combatting drug finally on its way to the FDA

August 16, 2022
Manufacturing and Production

BrainStorm Cell Therapeutics’ NurOne was rejected by the Food and Drug Association in February 2021 but this year, after consulting …

UK first country to approve bivalent booster which targets both original COVID-19 as well as the Omicron strain

August 16, 2022
Manufacturing and Production

The UK medicines regulator (MHRA) has given the Moderna-made vaccine conditional approval, backed up by the Joint Committee on Vaccination …

Sanofi and NIHR enrol first patient in immunisation study for RSV in infants

August 15, 2022
Sales and Marketing

The European study will evaluate the use of the human recombinant monoclonal antibody nirsevimab   Sanofi and the National Institute …

NHS England outlines measures to boost capacity ahead of substantial winter pressures

August 15, 2022
Sales and Marketing

The package of measures includes creating the equivalent of 7,000 additional hospital beds   NHS England has announced a package …

Focused ultrasound therapies could be made more affordable by 3D-printed acoustic holograms to help overcome the blood-brain barrier

August 15, 2022
Sales and Marketing

The 3D-printed acoustic hologram is used with focused ultrasound (FUS) to create a more controlled and precise opening in the …

brain_fgo

Cognitive rehabilitation therapy may help older adults clear COVID-19-related brain fog

August 15, 2022
Sales and Marketing

Medical centres in the US have started referring older patients with long COVID-19-related symptoms for cognitive rehabilitation in order to …

MHRA grants marketing authorisation for Novartis’ Pluvicto

August 12, 2022
Medical Communications

Radioligand therapy is used to treat patients with advanced prostate cancer

Bristol Myers Squibb and GentiBio in $1.9bn deal to develop inflammatory bowel disease therapies

August 12, 2022
Medical Communications

BMS will have the right to develop and advance up to three of the resulting programmes into clinical trials

blood_tests_pic

Blood tests taken within 24 hours of a traumatic brain injury can predict whether a patient will die, or survive with serious disability

August 12, 2022
Medical Communications

The tests’ results are available within minutes and will be useful in helping trauma ward staff and surgeons to decide …

booster

ONS figures show rapid decrease in people with higher COVID-19 antibody figures

August 12, 2022
Medical Communications

The amount of UK residents with higher levels of COVID-19 antibodies is falling, ONS statistics show.

Pfizer to buy Global Blood Therapeutics for $5.4bn

August 11, 2022
Business Services

Pfizer Inc is to pay $5.4 billion in cash to acquire sickle cell disease drug-maker Global Blood Therapeutics, according to …

All children aged one to nine in London to be offered polio vaccine

August 11, 2022
Business Services

The Joint Committee on Vaccination and Immunisation (JCVI) has advised that a targeted inactivated polio vaccine (IPV) booster be given …

hospital-1802680__340

NHS backlog of 22,500 longest-wait patients slashed to fewer than 200, says NHS England figures

August 11, 2022
Business Services

The COVID-19 pandemic caused a huge backlog in patients as medical services focused their efforts on combating the virus. At …

COVID-19 sewage surveillance labs join the hunt for monkeypox

August 11, 2022
Business Services

Wastewater surveillance techniques are being adapted for use in monitoring the spread of monkeypox across the San Francisco Bay Area …

x-ray-6841384__480

Study highlights major factors in shaping cross-disorder cortical abnormalities

August 10, 2022
Research and Development

The study began by constructing maps of cortical abnormalities from thirteen neurodevelopmental, neurological, and psychiatric disorders. These maps came from …

Survey reveals 45% of junior doctors are considering leaving the profession

August 10, 2022
Research and Development

1 in 3 (36%) of GPs and 1 in 4 (25%) of specialists surveyed were also looking to pursue a …

Karuna Therapeutics announces positive results from Phase III trial into schizophrenia

August 10, 2022
Research and Development

Karuna Therapeutics has announced positive topline results from its Phase III EMERGENT-2 trial, evaluating the efficacy, safety, and tolerability of …

Tagrisso combined with Hutchmed drug clears lung cancer test

August 10, 2022
Research and Development

Tagrisso and Hutchmed have revealed positive Phase II data on their combination drug, which prompts the two partners to progress …

The Gateway to Local Adoption Series

Latest content